Cargando…

Energy Metabolism in H460 Lung Cancer Cells: Effects of Histone Deacetylase Inhibitors

BACKGROUND: Tumor cells are characterized by accelerated growth usually accompanied by up-regulated pathways that ultimately increase the rate of ATP production. These cells can suffer metabolic reprogramming, resulting in distinct bioenergetic phenotypes, generally enhancing glycolysis channeled to...

Descripción completa

Detalles Bibliográficos
Autores principales: Amoêdo, Nívea Dias, Rodrigues, Mariana Figueiredo, Pezzuto, Paula, Galina, Antonio, da Costa, Rodrigo Madeiro, de Almeida, Fábio Ceneviva Lacerda, El-Bacha, Tatiana, Rumjanek, Franklin David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3138778/
https://www.ncbi.nlm.nih.gov/pubmed/21789245
http://dx.doi.org/10.1371/journal.pone.0022264
_version_ 1782208406179807232
author Amoêdo, Nívea Dias
Rodrigues, Mariana Figueiredo
Pezzuto, Paula
Galina, Antonio
da Costa, Rodrigo Madeiro
de Almeida, Fábio Ceneviva Lacerda
El-Bacha, Tatiana
Rumjanek, Franklin David
author_facet Amoêdo, Nívea Dias
Rodrigues, Mariana Figueiredo
Pezzuto, Paula
Galina, Antonio
da Costa, Rodrigo Madeiro
de Almeida, Fábio Ceneviva Lacerda
El-Bacha, Tatiana
Rumjanek, Franklin David
author_sort Amoêdo, Nívea Dias
collection PubMed
description BACKGROUND: Tumor cells are characterized by accelerated growth usually accompanied by up-regulated pathways that ultimately increase the rate of ATP production. These cells can suffer metabolic reprogramming, resulting in distinct bioenergetic phenotypes, generally enhancing glycolysis channeled to lactate production. In the present work we showed metabolic reprogramming by means of inhibitors of histone deacetylase (HDACis), sodium butyrate and trichostatin. This treatment was able to shift energy metabolism by activating mitochondrial systems such as the respiratory chain and oxidative phosphorylation that were largely repressed in the untreated controls. METHODOLOGY/PRINCIPAL FINDINGS: Various cellular and biochemical parameters were evaluated in lung cancer H460 cells treated with the histone deacetylase inhibitors (HDACis), sodium butyrate (NaB) and trichostatin A (TSA). NaB and TSA reduced glycolytic flux, assayed by lactate release by H460 cells in a concentration dependent manner. NaB inhibited the expression of glucose transporter type 1 (GLUT 1), but substantially increased mitochondria bound hexokinase (HK) activity. NaB induced increase in HK activity was associated to isoform HK I and was accompanied by 1.5 fold increase in HK I mRNA expression and cognate protein biosynthesis. Lactate dehydrogenase (LDH) and pyruvate kinase (PYK) activities were unchanged by HDACis suggesting that the increase in the HK activity was not coupled to glycolytic flux. High resolution respirometry of H460 cells revealed NaB-dependent increased rates of oxygen consumption coupled to ATP synthesis. Metabolomic analysis showed that NaB altered the glycolytic metabolite profile of intact H460 cells. Concomitantly we detected an activation of the pentose phosphate pathway (PPP). The high O(2) consumption in NaB-treated cells was shown to be unrelated to mitochondrial biogenesis since citrate synthase (CS) activity and the amount of mitochondrial DNA remained unchanged. CONCLUSION: NaB and TSA induced an increase in mitochondrial function and oxidative metabolism in H460 lung tumor cells concomitant with a less proliferative cellular phenotype.
format Online
Article
Text
id pubmed-3138778
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-31387782011-07-25 Energy Metabolism in H460 Lung Cancer Cells: Effects of Histone Deacetylase Inhibitors Amoêdo, Nívea Dias Rodrigues, Mariana Figueiredo Pezzuto, Paula Galina, Antonio da Costa, Rodrigo Madeiro de Almeida, Fábio Ceneviva Lacerda El-Bacha, Tatiana Rumjanek, Franklin David PLoS One Research Article BACKGROUND: Tumor cells are characterized by accelerated growth usually accompanied by up-regulated pathways that ultimately increase the rate of ATP production. These cells can suffer metabolic reprogramming, resulting in distinct bioenergetic phenotypes, generally enhancing glycolysis channeled to lactate production. In the present work we showed metabolic reprogramming by means of inhibitors of histone deacetylase (HDACis), sodium butyrate and trichostatin. This treatment was able to shift energy metabolism by activating mitochondrial systems such as the respiratory chain and oxidative phosphorylation that were largely repressed in the untreated controls. METHODOLOGY/PRINCIPAL FINDINGS: Various cellular and biochemical parameters were evaluated in lung cancer H460 cells treated with the histone deacetylase inhibitors (HDACis), sodium butyrate (NaB) and trichostatin A (TSA). NaB and TSA reduced glycolytic flux, assayed by lactate release by H460 cells in a concentration dependent manner. NaB inhibited the expression of glucose transporter type 1 (GLUT 1), but substantially increased mitochondria bound hexokinase (HK) activity. NaB induced increase in HK activity was associated to isoform HK I and was accompanied by 1.5 fold increase in HK I mRNA expression and cognate protein biosynthesis. Lactate dehydrogenase (LDH) and pyruvate kinase (PYK) activities were unchanged by HDACis suggesting that the increase in the HK activity was not coupled to glycolytic flux. High resolution respirometry of H460 cells revealed NaB-dependent increased rates of oxygen consumption coupled to ATP synthesis. Metabolomic analysis showed that NaB altered the glycolytic metabolite profile of intact H460 cells. Concomitantly we detected an activation of the pentose phosphate pathway (PPP). The high O(2) consumption in NaB-treated cells was shown to be unrelated to mitochondrial biogenesis since citrate synthase (CS) activity and the amount of mitochondrial DNA remained unchanged. CONCLUSION: NaB and TSA induced an increase in mitochondrial function and oxidative metabolism in H460 lung tumor cells concomitant with a less proliferative cellular phenotype. Public Library of Science 2011-07-18 /pmc/articles/PMC3138778/ /pubmed/21789245 http://dx.doi.org/10.1371/journal.pone.0022264 Text en Amoêdo et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Amoêdo, Nívea Dias
Rodrigues, Mariana Figueiredo
Pezzuto, Paula
Galina, Antonio
da Costa, Rodrigo Madeiro
de Almeida, Fábio Ceneviva Lacerda
El-Bacha, Tatiana
Rumjanek, Franklin David
Energy Metabolism in H460 Lung Cancer Cells: Effects of Histone Deacetylase Inhibitors
title Energy Metabolism in H460 Lung Cancer Cells: Effects of Histone Deacetylase Inhibitors
title_full Energy Metabolism in H460 Lung Cancer Cells: Effects of Histone Deacetylase Inhibitors
title_fullStr Energy Metabolism in H460 Lung Cancer Cells: Effects of Histone Deacetylase Inhibitors
title_full_unstemmed Energy Metabolism in H460 Lung Cancer Cells: Effects of Histone Deacetylase Inhibitors
title_short Energy Metabolism in H460 Lung Cancer Cells: Effects of Histone Deacetylase Inhibitors
title_sort energy metabolism in h460 lung cancer cells: effects of histone deacetylase inhibitors
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3138778/
https://www.ncbi.nlm.nih.gov/pubmed/21789245
http://dx.doi.org/10.1371/journal.pone.0022264
work_keys_str_mv AT amoedoniveadias energymetabolisminh460lungcancercellseffectsofhistonedeacetylaseinhibitors
AT rodriguesmarianafigueiredo energymetabolisminh460lungcancercellseffectsofhistonedeacetylaseinhibitors
AT pezzutopaula energymetabolisminh460lungcancercellseffectsofhistonedeacetylaseinhibitors
AT galinaantonio energymetabolisminh460lungcancercellseffectsofhistonedeacetylaseinhibitors
AT dacostarodrigomadeiro energymetabolisminh460lungcancercellseffectsofhistonedeacetylaseinhibitors
AT dealmeidafabiocenevivalacerda energymetabolisminh460lungcancercellseffectsofhistonedeacetylaseinhibitors
AT elbachatatiana energymetabolisminh460lungcancercellseffectsofhistonedeacetylaseinhibitors
AT rumjanekfranklindavid energymetabolisminh460lungcancercellseffectsofhistonedeacetylaseinhibitors